204 related articles for article (PubMed ID: 22015658)
21. Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature.
Oppi S; Nusser-Stein S; Blyszczuk P; Wang X; Jomard A; Marzolla V; Yang K; Velagapudi S; Ward LJ; Yuan XM; Geiger MA; Guillaumon AT; Othman A; Hornemann T; Rancic Z; Ryu D; Oosterveer MH; Osto E; Lüscher TF; Stein S
Eur Heart J; 2020 Mar; 41(9):995-1005. PubMed ID: 31529020
[TBL] [Abstract][Full Text] [Related]
22. Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function.
Bermudez B; Dahl TB; Medina I; Groeneweg M; Holm S; Montserrat-de la Paz S; Rousch M; Otten J; Herias V; Varela LM; Ranheim T; Yndestad A; Ortega-Gomez A; Abia R; Nagy L; Aukrust P; Muriana FJG; Halvorsen B; Biessen EAL
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1157-1167. PubMed ID: 28408371
[TBL] [Abstract][Full Text] [Related]
23. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
[TBL] [Abstract][Full Text] [Related]
24. Specific loss of toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice.
Hasu M; Thabet M; Tam N; Whitman SC
Can J Physiol Pharmacol; 2011 Oct; 89(10):737-42. PubMed ID: 21895526
[TBL] [Abstract][Full Text] [Related]
25. The effects of diet on occlusive coronary artery atherosclerosis and myocardial infarction in scavenger receptor class B, type 1/low-density lipoprotein receptor double knockout mice.
Fuller M; Dadoo O; Serkis V; Abutouk D; MacDonald M; Dhingani N; Macri J; Igdoura SA; Trigatti BL
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2394-403. PubMed ID: 25212235
[TBL] [Abstract][Full Text] [Related]
26. Brown Adipocyte-Specific PPARγ (Peroxisome Proliferator-Activated Receptor γ) Deletion Impairs Perivascular Adipose Tissue Development and Enhances Atherosclerosis in Mice.
Xiong W; Zhao X; Villacorta L; Rom O; Garcia-Barrio MT; Guo Y; Fan Y; Zhu T; Zhang J; Zeng R; Chen YE; Jiang Z; Chang L
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1738-1747. PubMed ID: 29954752
[TBL] [Abstract][Full Text] [Related]
27. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
[TBL] [Abstract][Full Text] [Related]
28. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice.
Silva JC; César FA; de Oliveira EM; Turato WM; Tripodi GL; Castilho G; Machado-Lima A; de Las Heras B; Boscá L; Rabello MM; Hernandes MZ; Pitta MG; Pitta IR; Passarelli M; Rudnicki M; Abdalla DS
Pharmacol Res; 2016 Feb; 104():49-60. PubMed ID: 26706782
[TBL] [Abstract][Full Text] [Related]
29. Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in Bone marrow-derived cells in LDL receptor knockout mice on western-type diet.
Zhao Y; Pennings M; Hildebrand RB; Ye D; Calpe-Berdiel L; Out R; Kjerrulf M; Hurt-Camejo E; Groen AK; Hoekstra M; Jessup W; Chimini G; Van Berkel TJ; Van Eck M
Circ Res; 2010 Dec; 107(12):e20-31. PubMed ID: 21071707
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice.
Netherland CD; Pickle TG; Bales A; Thewke DP
Atherosclerosis; 2010 Nov; 213(1):102-8. PubMed ID: 20846652
[TBL] [Abstract][Full Text] [Related]
31. Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice.
Tu P; Bhasin S; Hruz PW; Herbst KL; Castellani LW; Hua N; Hamilton JA; Guo W
Diabetes; 2009 Aug; 58(8):1739-48. PubMed ID: 19509018
[TBL] [Abstract][Full Text] [Related]
32. Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis.
Zhou Q; Mei Y; Shoji T; Han X; Kaminski K; Oh GT; Ongusaha PP; Zhang K; Schmitt H; Moser M; Bode C; Liao JK
Circulation; 2012 Oct; 126(18):2236-47. PubMed ID: 23011471
[TBL] [Abstract][Full Text] [Related]
33. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
[TBL] [Abstract][Full Text] [Related]
34. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
35. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice.
Kitamoto S; Sukhova GK; Sun J; Yang M; Libby P; Love V; Duramad P; Sun C; Zhang Y; Yang X; Peters C; Shi GP
Circulation; 2007 Apr; 115(15):2065-75. PubMed ID: 17404153
[TBL] [Abstract][Full Text] [Related]
36. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice.
Krishack PA; Bhanvadia CV; Lukens J; Sontag TJ; De Beer MC; Getz GS; Reardon CA
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26187995
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
[TBL] [Abstract][Full Text] [Related]
38. The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by peroxisome proliferator-activated receptor-gamma.
Davies BS; Waki H; Beigneux AP; Farber E; Weinstein MM; Wilpitz DC; Tai LJ; Evans RM; Fong LG; Tontonoz P; Young SG
Mol Endocrinol; 2008 Nov; 22(11):2496-504. PubMed ID: 18787041
[TBL] [Abstract][Full Text] [Related]
39. Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma}.
Subramanian V; Golledge J; Ijaz T; Bruemmer D; Daugherty A
Circ Res; 2010 Oct; 107(8):953-8. PubMed ID: 20798360
[TBL] [Abstract][Full Text] [Related]
40. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.
Lu Z; Zhang X; Li Y; Lopes-Virella MF; Huang Y
Immunobiology; 2015 Nov; 220(11):1246-54. PubMed ID: 26162692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
